FindTrial
Sign In

Clinical study of high volume hemofiltration in the treatment of critical hand foot and mouth disease

Clinical study of high volume hemofiltration in the treatment of critical hand foot and mouth disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-17013745
Enrollment
Unknown
Registered
2017-12-06
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hand-foot-and-mouth disease

Interventions

CRRT group:CRRT
Routine treatment group:conventional therapy

Sponsors

Children`s Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. The third phase of hand, foot and mouth disease (early stage of cardiopulmonary failure) is defined by the expert consensus on clinical treatment of severe cases of enterovirus 71 (EV71) infection (2011 Edition); 2. The blood pressure is greater than or equal to 70mmHg+2 * age; 3. Platelet over 50 * 10^9/L; 4. The guarder agreed to carry out HVHF treatment and sign the informed consent.

Exclusion criteria

Exclusion criteria: The patients with Hemodynamic instability

Design outcomes

Primary

MeasureTime frame
blood gas analysis;catecholamine;inflammatory factors;—

Countries

China

Contacts

Public ContactFu Yue-Qiang

Children`s Hospital of Chongqing Medical University

fuyueqiang@sina.com+86 15123134328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026